Publicerat: 2021-05-28 09:50:19

Respiratorius Q1 Review - Redeye

Redeye leaves a comment on Respiratorius following the release of the company’s report for the first quarter. We reiterate our Base case of SEK 2,8 and retain our positive stance on the company.

Länk till analysen

Läs mer om Respiratorius AB